Bianchi Davide 4
4 · Orthofix Medical Inc. · Filed Apr 3, 2019
Insider Transaction Report
Form 4
Bianchi Davide
Pres, Int'l Extremity Fixation
Transactions
- Award
Common Stock
2019-04-01+3,114→ 27,830 total - Award
Stock Option (right to buy)
2019-04-01+10,318→ 10,318 totalExercise: $56.20Exp: 2029-04-01→ Common Stock (10,318 underlying) - Award
Common Stock
2019-04-01+7,366→ 35,196 total - Award
Performance Share Units
2019-04-01+6,228→ 6,228 totalExercise: $0.00Exp: 2022-04-01→ Common Stock (6,228 underlying)
Footnotes (4)
- [F1]Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019.
- [F2]Represents time-based vesting restricted stock units that vest on the second anniversary of the grant date, April 1, 2019.
- [F3]These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019.
- [F4]Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2019 to April 1, 2022. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 1, 2019, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.